The Latest Roundup of ABMS Antitrust Lawsuits
Dr. Wes
SEPTEMBER 12, 2020
Since December 2018, a rash of antitrust lawsuits have been filed against the American Board of Medical Specialties (ABMS) and their member boards.
100 
At Long Last, FDA Unveils Plan for Rare Disease Innovation Hub
FDA Law Blog
JULY 17, 2024
An Opportunity to Leverage the Newly Created Rare Disease Advisory Committee across CDER and CBER In Frank and James’ 2018 proposal there was also a recommendation for the formation of a Rare Disease Advisory Committee, which would allow FDA access to experts in the science of small trials and other aspects of rare disease research.
The Future Of Vision And Eye Care
The Medical Futurist
JUNE 21, 2025
Their research showed promising results for lab rats, and they plan to carry out the first human trials in the second half of 2017 and gather preliminary results during 2018. Learn more about the technological future of medical specialties from our latest e-book ! The Stanford Artificial Retina Project shows great promises.
Let's personalize your content